Cancer Genetics to provide genetic testing platform to NextGxDx


Cancer Genetics (CGIX -1.5%) says NextGxDx has agreed to offer its genomic-based oncology tests and services through the NextGxDx platform.

NextGxDx Inc. provides an online genetic testing marketplace for healthcare professionals and hospitals, and CGIX's catalog of more than 100 regulatory approved oncology testing products and solutions will provide for easy search, comparison and ordering.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs